Msx2 is a homeobox gene with a regulatory role in inductive tissue interactions, including those that pattern the skull. We demonstrated previously that individuals affected with an autosomal dominant disorder of skull morphogenesis (craniosynostosis, Boston type) bear a mutated form of Msx2 in which a histidine is substituted for a highly conserved proline in position 7 of the N-terminal arm of the homeodomain (p148h). The mutation behaves as a dominant positive in transgenic mice. The location of the mutation in the N-terminal arm of the homeodomain, a region which in other homeodomain proteins plays a key part in protein-protein interactions, prompted us to undertake a yeast two hybrid screen for Msx2-interacting proteins. Here we present a functional analysis of one such protein, designated Mizl (Msx-interacting-zinc finger). Mizl is a zinc finger-containing protein whose amino acid sequence closely resembles that of the yeast protein, Nil-1. Together these proteins define a new, highly conserved protein family. Analysis of Mizl expression by Northern blot and in situ hybridization revealed a spatiotemporal pattern that overlaps that of Msx2. Further, Mizl is a sequence specific DNA binding protein, and it can function as a positive-acting transcription factor. Mizl interacts directly with Msx2 in vitro and enhances the DNA binding affinity of Msx2 for a functionally important element in the rat osteocalcin promoter. The p148h mutation in Msx2 augments the Mizl effect on Msx2 DNA binding, suggesting a reason why this mutation behaves in vivo as a dominant positive, and providing a potential explanation of the craniosynostosis phenotype.
Introduction
Inductive tissue interactions, in which signals from one tissue alter the fate of another, are essential for vertebrate embryogenesis. Secreted and membrane-bound signaling molecules, their receptors, and a series of intracellular signal transducers are key molecular components of inductive interactions (Davidson, 1993) . Equally important are systems of transcription factors that respond to and regulate such intracellular signaling pathways. Among these transcription factors are the Msx proteins. Named for Droso-et al., 1989; Davidson et al., 1991; Monaghan et al., 1991; MacKenzie et al., 1992; Jabs et al., 1993; Liu et al., 1996) . Msx3 is expressed exclusively in the developing central nervous system (Shimeld et al., 1996; Wang et al., 1996) .
A direct role for the Msx2 gene in skull development and in a human genetic disease was demonstrated by our observation that individuals affected with Boston craniosynostosis bear a mutated copy of Msx2 (Jabs et al., 1993) . Craniosynostosis is the premature fusion of calvarial bones with consequent abnormalities in skull shape (Cohen, 1986 (Cohen, , 1988 . Boston craniosynostosis is an autosomal dominant genetic disorder first described in a large group in the United States . It is one of approximately 100 genetic syndromes in which craniosynostosis is a feature (Cohen, 1986) . The Boston craniosynostosis mutation is a single base change that results in the substitution of a histidine for a proline in the highly conserved seventh position in the N-terminal arm of the homeodomain (p148h) (Jabs et al., 1993) . This mutation enhances the binding affinity of Msx2 without altering its site specificity (Ma et al., 1996) . Transgenic mice bearing a mutated copy of Msx2 exhibit many of the features of craniosynostosis (Liu et al., 1996) . Furthermore, overexpression of wild type Msx2 in transgenic mice can elicit a virtually identical phenotype. Thus, taken together, biochemical and genetic approaches suggest that the p148h mutation acts by a dominant positive mechanism (Liu et al., 1995 (Liu et al., , 1996 .
That a mutation in the N-terminal arm of Msx2 has a profound effect on its activity is consistent with a number of studies carded out with several homeodomain proteins that have demonstrated that the N-terminal arm influences both DNA binding and interactions with auxiliary proteins (Gehring et al., 1994; Mann and Chan, 1996; Zhang et al., 1996) . Residues 3, 5 and 7 make base specific contacts in the minor groove on the 5' side of the TAAT core sequence (Kissinger et al., 1990; Wolberger et al., 1991) . Residue 6 contacts the sugar phosphate backbone (Kissinger et al., 1990; Klemm et al., 1994) , and mutations in residues 6 and 7 affect base preferences throughout the region contacted by the N-terminal arm (Kissinger et al., 1990; Wolberger et al., 1991) . Interactions between homeodomain proteins and their partners, which have been postulated to enhance homeodomain binding specificity in vivo, have been documented between the yeast c~2 homeodomain protein and its partner MCM1 (Vershon and Johnson, 1993) , and between Hox proteins and PBC-class homeodomain proteins (Mann and Chan, 1996) . Both interactions depend on sequences N-terminal to the homeodomain, and both modify the DNA binding activity of their homeodomain cognates (Vershon and Johnson, 1993; Chan et al., 1994; van Dijk and Murre, 1994; Popperl et al., 1995) , lending credence to the long held view that homeodomain/partner protein interactions are fundamental to the biological specificity of homeodomain proteins.
These findings suggested to us that the p148h mutation might, in addition to affecting Msx2 DNA binding, influence the interaction between Msx2 and partner proteins. To understand the molecular basis of Boston craniosynostosis, and more generally, to investigate the role of parmer proteins in homeodomain protein function, we undertook a yeast two hybrid screen for Msx2 interacting proteins. Here we describe the isolation of a cDNA encoding a novel zinc finger protein, designated Mizl (Msx-interacting-zinc finger), that interacts with Msx2 in vivo (in yeast) and in vitro. We demonstrate that Mizl is a sequence specific DNA binding protein and a positive acting transcription factor. We show that it enhances the binding affinity of Msx2 for a functionally important element in the rat osteocalcin promoter, and finally, we demonstrate that the Msx2 p148h (Boston craniosynostosis) mutation augments the Mizl dependent enhancement of Msx2 DNA binding, providing a possible explanation for the Boston craniosynostosis phenotype in humans.
Results

A yeast two hybrid screen for Msx2-interacting proteins
We used the yeast two hybrid system as an initial screen for proteins capable of interacting with Msx2 (Fields and Song, 1989) . We created an expression construct containing Msx2 fused with the GAL4 DNA binding domain. This construct was transformed into the yeast strain PCY2 bearing a mouse E14.5 day cDNA library fused with the GAL4 transactivation domain (Chevray and Nathans, 1992) . We screened a total of 1 × 106 transformants for their ability to produce ~-galactosidase in a filter lift assay, obtaining 48 positive clones. These were subjected to further analysis for the specificity of their interaction with Msx2. Plasmids were isolated from the ~-galactosidase-positive yeast colonies and were used to transform PCY2, or were co-transformed with plasmids bearing the GAL4 DNA binding domain, the GAL4 binding domain fused to wild type Msx2, or the GAL4 DNA binding domain fused to an irrelevant protein.
Transformants were assayed for /~-galactosidase activity and those showing activity only in the presence of the Msx2 GAL4 hybrid were considered positive. Of the 48 original isolates, 27 met these criteria. We obtained partial nucleotide sequences and derived amino acid sequences of each of these 27 isolates, and used the amino acid sequences to search the Genbank/EMBL database. This revealed three classes of clones. One, represented by 22 isolates, encoded a molecule related to the ubiquitin conjugating enzyme family (L. Ma, L. Wu and R. Maxson, unpublished data) . The second class, represented by three clones, was the K subunit of the multicatalytic protease, a component of the proteosome (data not shown). The third class, of which we obtained two clones, was a novel sequence that had several interesting structural features consistent with a role as an Msx2 partner transcription factor. Here we describe the Mizl interacts specifically with Msx2 in yeast. Mizl was isolated from a library of fusions in the expression vector pPC86 on the basis of its ability to activate a GALI-IacZ reporter gene in the presence of the GBD/Msx2 hybrid. Quantitative 13-galactosidase assays (ONPG hydrolysis) were conducted after transformation with the indicated plasmids. The average of three independent transformants is given. All the strains contain a single copy plasmid which carries a yeast centromere (CEN6). The hybrids were expressed from the strong constitutive ADC! promoter.
further characterization of this third class of clones, which we designate Mizl.
Mizl and the yeast protein, Nfi-1, define a new, highly conserved family of zinc finger proteins
Quantitative 13-galactosidase assays showed that the Mizl protein interacted specifically with Msx2 in the yeast two hybrid system (Table 1) . A complete nucleotide sequence of the Mizl cDNA (1.9 kb in length) revealed an open reading frame of 490 amino acids and a predicted molecular mass of 65 kDa (Fig. 1) . A consensus translation start sequence preceded this open reading frame and a poly-A addition site was located approximately 500 bp downstream of the translation termination codon. The predicted amino acid sequence of Mizl showed a cysteine-rich region in the central portion of the molecule, and within this region, a single zinc finger with the unusual structure of H-C3. Adjacent to the zinc finger, both N-terminal and C-terminal, were several short stretches of basic amino acids. Additional sequence motifs included a proline-rich region in the Nterminus closely resembling an SH3 binding domain of the GAP protein, 3BP-1 (Cicchetti et al., 1995) , and a serine/threonine-rich domain near the C-terminus. A protein database search (Fig. 2) revealed that the Mizl sequence is most similar to Nfi-1, a yeast (S. cerevisiae) protein of unknown function identified in a yeast two hybrid screen for proteins that can interact with yeast septin, a bud neck filament protein (Genebank; Longtine et al., 1996) . Mizl also matched closely a yeast open reading frame, gi927340, obtained from the yeast genome sequencing project. The match between Mizl and the two yeast sequences was highly significant, greater by approximately 21 orders of magnitude than the match to the next most similar sequence. Several regions of similarity were evident. An N-terminal segment of Mizl (residues 31-120 of Mizl) was 45% similar to the Nfi-1 sequence, and a 107 residue region of Mizl including the zinc finger (residues 190-296) was 64% similax to Nfi-1 (Fig. 2) . A stretch of 154 amino acids in the Cterminal region of Mizl (residues 301-454) was 43% similar to Nil-1. Also, the serine-threonine rich domain in the Cterminal region showed some similarity to transactivation domains of a variety of transcription factors, including for example, the Thyrotroph Embryonic Factor (TEF), a bZip protein expressed in the developing pituitary (Drolet et al., 1991) (not shown).
A Mizl probe, which was determined to be gene-specific by genomic Southern blot analysis (data not shown), hybridized with a transcript of approximately 2 kb, similar in size to the cDNA (Fig. 3) . Although we cannot rule out additional protein-coding sequence upstream of the ATG, our data are consistent with the view that the Mizl cDNA encodes a full-length or near full-length Mizl protein. Also consistent with this possibility is the fact that the Nterminal region of Mizl was similar in sequence to the Ntermini of both Nfi-1 and gi927340. The primary structure of Mizl thus suggested that it is a DNA binding protein and perhaps a transcription factor, prompting us to characterize Mizl in greater detail and to further test the hypothesis that it interacts functionally with Msx2.
The expression pattern of Mizl overlaps with that of Msx2
If Mizl acts as an Msx2 cofactor during murine embryogenesis, then the expression patterns of these genes must overlap. Northern blot analysis of poly A-containing RNA from whole embryos from day E9.5 through E14.5, and the heads of E15.5 embryos revealed Mizl transcripts at all stages examined. Msx2 expression is first detectable in E6.5 embryos (Hill et al., 1989; A. Lazik and R.' Maxson, unpublished data) , and continues in a complex and dynamic pattern throughout embryogenesis and into neonatal life (Davidson, 1995) . Hybridization of the same blot shown in Fig. 3 to an Msx2 probe revealed Msx2 transcripts in all RNA samples (Bell et al., 1993) . Mizl and Msx2 are thus coexpressed temporally during embryonic development, and both are expressed in the developing face and brain.
To determine whether Msx2 and Mizl are also coexpressed spatially, we carried out an in situ hybridization analysis on murine embryos from embryonic day 9 (E9) through embryonic day 16 (E16). We found that Mizl transcripts were distributed broadly in embryos in a pattern that encompassed the expression domain of Msx2. Two examples of the relationship between Msx2 and Mizl domains of expression are shown in Fig. 3B -G. In a frontal section of an El0.5 mouse embryo, Msx2 transcripts were detectable in the anterior portions of the mandible and maxilla. Mizl transcripts were also present in the mandible and maxilla, but were more generally distributed. Similarly, Msx2 was expressed in the neural tube, along the dorsal midline, while Mizl was expressed throughout the neural tube. Msx2 was strongly expressed in neural crest-derived mesenchyme lateral to the hindbraln. Mizl was also expressed in this tissue. Fig. 3 shows that in E13.5 embryos, Msx2 transcripts were localized in the gonad. Mizl transcripts were also present in the gonad, as well as in surrounding tissues, including the kidney. The expression patterns of Msx2 and Mizl thus overlap at a variety of sites in the murine embryo, demonstrating that the protein products of these genes likely have the opportunity to interact in vivo. The distribution of Mizl transcripts in regions outside domains of Msx2 expression shows that the function of Mizl is likely to extend beyond its potential relationship with Msx2.
Mizl is a sequence specific DNA binding protein
That Mizl contains a zinc finger motif suggested that it might be a sequence-specific DNA binding protein. We used a DNA binding site selection assay to test this prediction (Catron et al., 1993) . We prepared a set of oligonucleotides consisting of 14 randomized bases flanked by a common sequence of 15. Opposite strands were synthesized and the resultant double stranded oligonucleotides were end-labeled and allowed to bind purified Mizl. The Mizl protein was obtained by expression in bacteria as an MBP fusion protein and was purified by affinity chromatography on a maltose column. SDS polyacrylamide gel analysis of the pure protein revealed a prominent band of the expected size and several minor products of lower molecular weight, presumably degradation products (not shown). We incubated MBPMizl with the random oligonucleotide mix and size-separated the protein-DNA complexes on a native acrylamide gel. The complexes were gel purified and the selected oligonucleotides were amplified by PCR. We carried out three rounds of binding and purification, and after the final round, cloned and sequenced the selected oligonucleotides. An alignment of the selected sequences ( Fig. 4A ) revealed a GC rich consensus sequence with two absolutely conserved G residues in the center.
To confirm that Miz 1 binds specifically to this consensus sequence, we carried out an electrophoretic mobility shift analysis in which we tested the influence of specific mutations in the consensus sequence on the ability of Mizl to bind (Fig. 4B) . A double stranded oligonucleotide bearing a consensus Mizl binding site was radiolabeled and allowed to bind affinity-purified Mizl. Varying amounts of a nonlabeled competitor oligonucleotide were added to the reaction. The competitor was either a non-labeled version of the labeled oligonucleotide or a mutant version in which the two conserved G residues in the center of the consensus sequence were mutated to As. Fig. 4B shows that whereas wild type non-labeled Mizl consensus sequence competed effectively for Mizl binding, the mutant form of this nonlabeled oligonucleotide did not compete. These data demonstrate that mutation of the two central G residues of the Mizl consensus substantially reduced Mizl binding, and therefore, that Mizl is a sequence specific DNA binding protein.
Mizl transactivates the Gall promoter
The similarity between the transactivation domains of several transcription factors and the C-terminal region of Mizl suggested to us that Mizl might have transactivation activity. We therefore fused the Mizl sequence with the GAL4 DNA binding domain and tested the ability of this fusion protein to transactivate the yeast GALl promoter. A plasmid bearing the Mizl-GAL4 DNA binding domain fusion was transfected into yeast strain PCY2 and/3-galactosidase activity was measured. As a negative control, the GAL4 DNA binding domain alone was transfected into PCY2. Yeast bearing the Mizl GAL4 DNA binding fusion protein had substantially higher/3-galactosidase levels than the control (Fig. 5) . Hence, Mizl can function as a positively-acting transcription factor with the yeast GALl promoter. A C-terminal deletion of the putative Mizl transactivation domain substantially reduced /3-galactosidase levels (Fig. 5) , consistent with the view that the transactivation domain is located in the C-terminal region of Mizl. Since the ability of Mizl to interact with Msx2 in the yeast two hybrid system was not affected by this same deletion (data not shown), instability of the mutant Mizl protein was probably not the cause of its reduced transactivation activity.
Mizl interacts directly with Msx2 and enhances its affinity for DNA
Data from the yeast two hybrid analysis demonstrate that Mizl can interact specifically with Msx2 in yeast. To determine whether Mizl can interact directly with Msx2, we carried out a glutathione-S-transferase (GST) affinity purification experiment. We created an in-frame fusion of GST and Mizl, bound the GST-Mizl protein to a glutathione affinity matrix, and incubated this mixture with the radiolabeled products of an in vitro translation of Msx2 mRNA. GST-ras served as a negative control. Affinity matrices containing GST-Msx2 or GST-ras were washed extensively, and the bound proteins were eluted and separated on an SDS-polyacrylamide gel. We found (Fig. 6A ) that GSTMizl was able to complex with Msx2 whereas GST-ras was not. A substantial portion of the input Msx2 protein bound to the Mizl beads, consistent with the view that the two proteins can bind each other avidly enough for their interaction to be biologically significant. ., 1994b) . Point mutations within this site abolish these effects, leading to the hypothesis that Msx2 functions cooperatively with other proteins through the Oc box. We noticed that the Oc box contains, in addition to the Msx binding site, GC rich regions that fit the Mizl consensus (Fig. 6B) . We therefore asked whether Mizl is capable of interacting with these sites, and whether it can modify the DNA binding ability of Msx2. We carried out electrophoretic mobility shift assays using affinity purified MBP-Mizl and a radiolabeled oligonucleotide bearing the Oc box. Data presented in Fig. 6B show that Mizl could indeed bind this element and that as expected, Msx2 also bound, producing an abundant complex (B) and a more slowly migrating, less distinct, and less abundant complex (A). Most interestingly, when Msx2 and Mizl were mixed and incubated with the Oc box, we observed a substantial enhancement (10-fold or greater) in the levels of both complexes. Prior heat treatment of Mizl reduced the amounts of both A and B complexes, consistent with the view that they are dependent on intact Mizl protein, and are not merely non-specific consequences of protein or ionic constituents of the reaction mixture. Also supporting the view that the enhancement of Msx2 binding is a specific effect of Mizl is the finding that MBP, expressed and purified in parallel with MBP-Mizl, did not produce the effect, nor did the addition of BSA. The enhancement of Msx2 binding was not a consequence of the MBP-Msx2 fusion per se, since a GST-Mizl fusion was also capable of enhancing Msx2 DNA binding (data not shown). As a control for the specificity of the Mizl effect, we tested the ability of Mizl to enhance the binding of the MADS box factor, MEF-2, to its binding site. We used an oligonucleotide bearing both an Mizl site and a consensus MEF-2 site located 10 bp apart. Both Mizl and MEF-2 bound this oligonucleotide (Fig. 6C) , producing complexes of virtually identical electrophoretic mobility. However, co-incubation of Mizl and MEF-2 produced a complex equal to and not greater than the intensities of the MEF-2 and Mizl complexes together. Thus Mizl did not enhance the binding of MEF-2. The ability of Mizl to enhance DNA binding is therefore not general.
Yeast two hybrid and GST pull down data demonstrating that Mizl and Msx2 can interact physically prompted us to
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The Boston craniosynostosis mutation in the Nterminal arm of Msx2 (p148h) enhances the cooperative interaction between Msx2 and Mizl
Our biochemical data as well as genetic data in the mouse and human are consistent with the view that the p148h mutation in Msx2 is a hypermorph (Liu et al., 1995; Ma et al., 1996) . Rather subtle (less than 5-fold) overexpression of Msx2 in transgenic mice can mimic the effect of the p148h mutation (Y.H. Lin and R. Maxson, unpublished observations), suggesting that the mutation need not cause a major increase in Msx2 activity in order to produce craniosynostosis. In initial experiments, we used GST-affinity chromatography to qualitatively test the ability of Msx2 p148h to interact with Mizl. Using the same approach described above for the wild type Msx2 (Fig. 6A) , we found that p148h mutation did not have a major quantitative effect on the Msx2-Miz 1 interaction (Fig. 6B) . However, the mutation did appear to enhance the Msx2-Mizl interaction approximately 2-fold. Since we expected that a subtle effect on the Msx2-Mizl interaction could be significant, we investigated the interaction more quantitatively using both yeast two hybrid and gel shift approaches.
A GAL4 DNA binding domain fusion bearing Msx2p148h was created and transfected into yeast together with the GAL4 TA-Mizl construct. In several independent transfections, Msx2p148h interacted approximately 30% more avidly with Mizl than did its wild type counterpart (Fig. 7A) . To test whether the p148h mutation could influence the Mizl effect on Msx2 DNA binding, we carried out titration experiments in which we mixed varying amounts of either wild type or p148h Msx2 with a constant amount of Miz 1 and measured binding to the Oc box oligonucleotide by gel shift assay. As can be seen in Fig. 7B , Mizl caused a greater leftward shift in the binding titration of p148h Msx2 than it did for wild type Msx2. Thus, per unit of Msx2 DNA binding activity, Mizl enhanced the DNA binding activity of Msx2 p148h approximately 2-3-fold more than was the case for wild type Msx2. This observation was reproducible with different preparations of bacterially-expressed Mizl and Msx2 protein (data not shown). The agreement between the yeast two hybrid and DNA binding titration data argues strongly that the p148h mutation enhances the avidity of the interaction between Msx2 and Mizl. The correlation between the hypermorphic activity of the p148h mutation in mammals and the enhancement of the interaction with Mizl in yeast and in vitro is consistent with the hypothesis that Mizl is a bona fide Msx2 cofactor and that the Msx2-Mizl interaction is relevant to the craniosynostosis phenotype.
Discussion
Here we describe a new gene, Mizl, isolated in a yeast two hybrid screen for proteins that can interact with the Msx2 homeoprotein. Several lines of evidence suggest that the Mizl-Msx2 interaction is functionally significant: (a) Mizl is a sequence specific DNA binding protein and a positive-acting transcription factor, properties expected of a The Mizl open reading frame, encoding a sequence of 490 amino acids, is most similar to the yeast protein, Nil-l, cloned in a yeast two hybrid screen for proteins that interact with septin, a protein involved in cytokinesis (Genebank; Longtine et al., 1996) . A second yeast sequence, gi927340, known only as an open reading frame (Genebank), is also very closely related to Mizl. There is as yet no direct evidence that Nil-1 can interact with septin in vivo; thus the function of Nil-1 in yeast remains unclear (J. Pringle, pers. commun.). The sequences of Nil-l, gi927340 and Mizl match quite closely, particularly in a 143 amino acid stretch including and flanking the zinc finger region, in which the similarity is nearly 70%. The domain structures of Nil-l, gi927340 and Mizl are also similar. All possess prolinerich domains that resemble SH3 binding motifs, as well as serine-threonine rich regions, and single zinc fingers with the unusual structure of HC3. This high degree of similarity between these proteins despite the evolutionary distance between yeast and mammals suggests that they are members of an ancient protein family, and that they may have related and conserved functions.
The single zinc finger of Mizl places it among a small group of proteins that includes the GAGA and GATA factors (Granok et al., 1995) . Until recently, it was believed that DNA binding requires two or more zinc fingers. Work on the GAGA factor has shown that a single zinc finger, likely in combination with one or more adjacent basic regions, is sufficient f o r DNA binding (Pedone et al., 1996) . Such binding can be disrupted by Zn 2÷ chelators, suggesting a direct role for the zinc finger in DNA binding. Mizl resembles these proteins in that (a) it contains several stretches of basic amino acids flanking the single zinc finger, and (b) it exhibits sequence-specific binding to a short, G-rich DNA sequence. Mizl may thus bind DNA by a mechanism similar to that of the GATA and GAGA factors. (Fig. 4) , is located in the GC-rich region at the 5' end of the oligonucleotide.
The C-terminal serine-threonine rich domain of Miz 1 is similar in amino acid composition to the transactivation domains of a variety of transcription factors. Moreover, Mizl can function as a transcription factor, stimulating transcription of the Gall promoter in yeast, as well as several mammalian promoters, including an MMTV minimal promoter in Chinese hamster lung fibroblasts (data not shown). Deletion of the C-terminal serine-threonine rich domain eliminates the ability of Mizl to transactivate GALl, but does not alter the ability of Mizl to interact with Msx2. Thus it appears that the serine-threonine rich domain is indeed a transactivation domain, and further, that the transactivation and protein-protein interaction domains are distinct.
Data obtained from yeast two hybrid and GST-affinity purification experiments show that Mizl can interact specifically with Msx2 in vivo and in vitro. Also consistent with the possibility that these proteins interact in vivo is the temporal and spatial overlap in the expression of Msx2 and Mizl during murine embryogenesis. More compelling evidence that Mizl interacts functionally with Msx2 is that Miz 1 can dramatically enhance the interaction of Msx2 with a DNA element in the rat osteocalcin promoter. This element, designated the Oc box, is required for the Msx2-mediated downregulation of the osteocalcin gene in MC3T3-E1 cells (Towler et al., 1994b) . Cotransfection experiments have shown that Miz) can potentiate this downregulation (D. Towler and R. Maxson, unpublished data) .
There are two general models that can account for the Mizl effect on Msx2 DNA binding. (a) In the first, a 'classical cooperativity' model, Mizl interacts stably with a DNA target sequence adjacent to an Msx2 binding site. This interaction would then enhance the ability of Msx2 to bind its target site. The key feature of this model is that it requires a stable interaction between Mizl and DNA or between Mizl and Msx2. This model is exemplified by the interaction between Hox proteins and PBC class homeodo- Msx2 (arbitrary DNA binding units) Fig. 7 . Influence of the Boston craniosynostosis (p148h) mutation in Msx2 on the interaction between Msx2 and Mizl. We used both the yeast two hybrid system (A) and gel shift analysis (B) to test the influence of the Boston craniosynostosis p148h mutation on the interaction between Msx2 and Mizl. (A) Constructs bearing either an Msx2 wild type-GAL4 DNA binding domain (DB) fusion, or an Msx2 p148h-GAL4 DB fusion were cotransfected into yeast with an Mizl-GAL4 TA fusion and a Gal-1 lacZ reporter. All yeast strains contain single copy plasmids which carry a yeast centromere (CEN6). The hybrids were expressed from the strong constitutive ADC1 promoter. LacZ activity was measured by ONPG hydrolysis. The mean lacZ activities from five independent experiments + SEM are shown. (B) To test directly the effect of the p148h mutation on the ability of Mizl to enhance the binding of Msx2 to the Oc element, we carded out a DNA binding titration experiment. Varying amounts of GST-Msx2 or GST-Msx2p148h were incubated with a constant amount of MBP-Mizl (100 ng) and radiolabeled Oc box oligonucleotide (5000 cpm). Since Msx2p148h binds DNA several-fold more avidly than Msx2 wild type (Ma et al., 1996) , the amounts of GST-Msx2 and GST-Msx2p148h were adjusted to equalize the DNA binding activity. Binding was assayed by EMSA. Examples of autoradiograms of portions of EMSA gels are shown in the upper left. Radioactivity in Msx2-DNA complexes and in free probe was quantitated in a phosphoimager. The results of four independent experiments + SEM are shown in the graph.
main proteins (Mann and Chan, 1996) Gilman and colleagues have demonstrated a hit and run mechanism in the interaction between the serum response factor (SRF) and the homeodomain protein, Phoxl (Grueneberg et al., 1992) . They showed that Phoxl enhances the binding of SRF to its target site, and that mutations in the homeodomain of Phoxl that prevent DNA binding do not affect the ability of Phoxl to enhance the binding of SRF. Kinetic experiments showed that SRF binds its target sequence more slowly than typical, diffusion-limited DNA binding proteins, and that Phoxl enhances the rate of stable complex formation. These data led to the proposal that Phoxl lowers an activation energy barrier, resulting in the rapid formation of stable SRF-DNA complexes (Grueneberg et al., 1992) . Whether a similar mechanism applies to the Mizl effect on Msx2 binding remains to be determined. It is intriguing that the p148h mutation in the N-terminal arm of Msx2 enhances Msx2 binding several-fold (Ma et al., 1996) , and as we have shown here, also enhances the ability of Mizl to augment Msx2 binding. Given that the N-terminal arm contacts DNA in the minor groove and has a key part in the specificity of homeodomain-DNA interactions (Gehring et al., 1994) , it is reasonable to propose that Mizl affects the interaction between the arm and DNA. Through such interactions, Mizl may influence the rate of formation of stable Msx2-DNA complexes, the rate of decay of such complexes, or both.
Our finding that Mizl can function as a sequence-specific transcription factor, taken together with indications that it may enhance the binding of Msx2 to DNA by a hit and run mechanism, suggest that Mizl has two distinct modes of action: (a) it may function independently as a transcription factor; and (b) it may modify the DNA binding activity, and thus the transcription regulatory activity, of Msx2. These activities presumably are not mutually exclusive; thus modulation of the relative amounts of Miz 1, an activator, and of Msx2, usually a repressor (Davidson, 1995; Zhang et al., 1996) , could lead to dramatically different transcriptional outcomes on a promoter such as osteocalcin which has both Mizl and Msx2 binding sites.
To what extent might the effect of the p148h mutation on the Msx2-Mizl interaction contribute to the molecular pathogenesis of Boston-type craniosynostosis? We showed previously that the p148h mutation enhances the DNA binding affinity of Msx2 several-fold without altering its sequence preferences (Ma et al., 1996) . This result, together with our demonstration here that the p148h mutation also enhances the cooperative interaction between Msx2 and Mizl, is consistent with genetic data suggesting that the p148h mutation is a hypermorph, and provides a working framework for understanding the pathogenesis of Boston-type craniosynostosis in terms of the macromolecular interactions of Msx2. Although the magnitude of this effect is only 2-3-fold, when combined with the influence of the mutation on DNA binding, the net effect becomes 8-15-fold, sufficient to be biologically significant. The p148h mutation may, of course, affect the interaction of Mizl with other proteins as well. TBP, for example, interacts with the N-terminal arm of Msxl, a close relative of Msx2 (Zhang et al., 1996) . This interaction mediates, in part, the transcription repressor activity of Msxl. Given the potential of the p148h mutation to influence macromolecular interactions of Msx2, it will be very interesting to examine the Mizl-Msx2 interaction in vivo, and to test the effect of the p148h mutation on this interaction.
Experimental procedures
Construction of GAL4 fusion vectors
Wild type and P148HMsx2 cDNAs were isolated as BamHI-EcoRI fragments and cloned into the BamHI and EcoRI sites of pSP73 (Promega) as an intermediate step.
The inserts were excised with BamHI and BgllI, and cloned into the unique BgllI site of pPC97, thus generating pPC97wtMsx2 and pPC97mutMsx2, respectively. Mizl cDNAs were isolated as SalI-NotI or SalI-SacI fragments and cloned into corresponding sites of PC97 to generate pPC97-Mizl and pPC97-MizlD, respectively. These constructs were sequenced to confirm the reading frames.
Yeast two hybrid screen of GAL4(TA) cDNA library
Yeast two hybrid vectors and a mouse E14.5 day embryonic cDNA library were kindly provided by Dr Pierre Chevray. Yeast PCY2 transformed with the pPC97Msx2 and selected on SC-Leu medium. A single colony grown on the SC-Leu medium was transformed with library DNA using salmon sperm DNA as carrier, and plated at a density of 2 x 103 colonies per 100 × 15 mm 2 plate of supplemented synthetic dextrose lacking tryptophan and leucine, and incubated at 30°C for 2-3 days. Transformants in which GAL4 activity had been reconstituted were identified by a colony filter/3-galactosidase assay procedure (Breeden and Nasmyth, 1985) . Colonies corresponding to positives in this screen were then patched onto a master plate and analyzed further.
Sequence analysis
cDNAs were cloned into pBluescript II KS(-) (Stratagene), and sequenced on both strands with Sequenase (United States Biochemical) according to the manufacturer's protocol. Sequences were managed with a software package from IntelliGenetics.
Expression and purification of Mizl
The Mizl cDNA was digested with Sail and NotI, bluntended with Klenow polymerase, and subcloned into the XmnI site of the bacterial expression vector pMAL-C2, thus permitting Mizl to be expressed as a maltose binding protein (MBP) fusion. Bacteria containing pMAL-C2-Mizl were grown to a density of 0.5 OD units, and protein expression was induced by adding 0.3 mM isopropylthiogalactoside. After 2 h, cells were harvested, lysed by sonication, and the protein was passed through to a maltose affinity column. MBP-Mizl fusion protein was eluted from the column with a buffer containing maltose (20 mM Tris-HC1 (pH 7.4), 200 mM NaC1, 1 mM EDTA, 1 mM dithiothreitol, 1 mM PMSF and 10 mM maltose). Prior to EMSA, the purified protein was dialyzed against 25 mM sodium phosphate (pH 7.4), 50 mM KC1, 5 mM MgC12, 10% (v/v) glycerol and 1 mM dithiothreitol.
To construct GST-Mizl, a SalI-NotI fragment containing the full length Mizl cDNA was blunt-ended with Klenow and subcloned into the SmaI site of pGEX-3X. To construct GST-Msx2 wild type and GST-Msx2Pro148His, pBSKwtMsx2 or pBSK-Msx2C---> A (Liu et al., 1995) were digested with BamH1 and EcoR1 and the resultant fragments were cloned directionally into the BamHI-EcoRI digested pGEX-3X, resulting in an in-frame fusion of GST with wild type or mutant Msx2. Plasmids encoding the fusion proteins were transformed into the bacterial strain BL21. Bacteria were grown and GST-Msx2 fusions were induced with IPTG (Ausubel et al., 1995) . To purify GSTMsx2 fusions, the bacterial pellets were resuspended in 1 mM PMSF and 1 mM EDTA in cold phosphate buffered saline (PBS). Cell were then lysed on ice by sonication and bacterial debris spun down at 12000 x g for 1 h. A slurry of GST beads (200/~l) was added to the supernatant and incubated at 4°C with shaking for 2 h. The beads were then pelleted at 1000 x g for 2 min and washed four times with PBS plus 1% Triton-X100 and 0.5% Nonidet P-40. The GST fusion proteins were eluted with 200/zl of GST elution buffer (5 mM reduced glutathione in 50 mM Tris-C1, pH 8.0).
RNA gel blots 4.7. In vitro protein-protein binding assay
RNA was extracted from murine embryos with guanidinium isothiocyanate (Chirgwin et al., 1979) and poly (A)-containing RNA was purified by oligo(dT) cellulose chromatography. Poly(A)-containing RNA (I0 /zg) was sizeseparated on formaldehyde-agarose gels and blotted on a nylon membrane. DNA probes were radiolabeled by random priming. Prehybridization and hybridization were carded out in QuickHyb (Stratagene) at 65°C according to the manufacturer's instructions. The filters were washed in 0. lx SSC at 65°C and exposed to X-ray film.
Electrophoretic mobility shift analysis and binding site selection
Oligonucleotide probes were prepared by radiolabeling with T4 polynucleotide kinase in the presence of [,y_32p ]_ ATP at 37°C for 60 min (Ausubel et al., 1995) . Binding assays were carried out by adding proteins to a buffer containing 25 mM Hepes (pH 7.5), 150 mM NaC1, 1 mM EDTA, 5% glycerol, 5 mM DTI', 0.5 mM PMSF and 1 t~g poly (dI-dC) (Fried and Crothers, 1984; Ausubel et al., 1995) . After incubation for 10 min at room temperature, radiolabeled DNA probe (2 x 104 cpm) was added, and the incubation was continued for another 15 min. DNAprotein complexes were separated from free DNA on 5% polyacrylamide gels containing lx Tris-glycine buffer.
The Msx-class oligonucleotide, based on the results of Catron et al. (1993) was as follows: 5'-AGCTTCAC-TAATTGGAGGA-3'. Equimolar amounts of this oligonucleotide and its complementary strand were mixed, heated to 90°C, and gradually cooled to room temperature; 250 ng of annealed primers were labeled with [3,-32p]ATP using T4 polynucleotide kinase.
Binding site selection was carried out largely as described (Catron et al., 1993) . We synthesized an oligonucleotide mixture comprising a random 14-bp sequence flanked by two 15-bp nonrandom sequences (5'-AGACGGATC-CATTGCA(N14)CTGTAGGAATTCGGA-3'). This mixture was amplified by PCR with two primers (5'-TCC-GAATTCCTACAG-3') and (5'-AGACGGATCCATTG-CA-3'). The resultant double-stranded fragment was radiolabeled with T4 polynucleotide kinase in the presence of [-r-32p]ATP and used as a probe in gel retardation assays. The protein-DNA complexes were separated from unbound DNA on a non-denaturing 5% polyacrylamide gel. Bound DNA was recovered from the gel by incubation in 0.5 M LiOAc and used as a template for PCR. The amplified DNA was subjected to two additional rounds of binding and purification. After the final round of PCR amplification, the gelpurified DNA fragments were digested with EcoRI and BamHI and cloned into corresponding sites of pBluescript (Stratagene). Ligated DNA was then transformed into E. coli (DH5a). Miniprep DNA was prepared and sequenced by the dideoxy chain termination method. pBSK-Msx2 was linearized with EcoRI and transcribed with T3 RNA polymerase as suggested by the manufacturer (Ambion). Msx2 protein was labeled with 40 #Ci of 35S-methionine (Amersham) by translation in vitro in a rabbit reticulate lysate (Promega). About 1/10 of the total Msx2 translation reaction was mixed with 10 /~1 of glutathione beads carrying different fusion proteins. The final volume was adjusted to 1 ml using PBS. After rotating at 4°C for 4 h, the beads were spun down at 1000 x g and washed twice with PBS plus 1% Triton X-100. The beads were then washed with PBS plus 1% Triton X-100 and 0.05% Nonidet P-40, mixed with 20/~1 of 2x SDS sample loading buffer, boiled for 5 min and loaded onto a 10% SDS-PAGE. The gel was run at 90 V, dried, and exposed to XAR-5 film for 2 days at room temperature.
In situ hybridization
To generate a probe for the in situ hybridization analysis, we isolated the 5' cDNA of Mizl as a SmaI and PstI fragment and subcloned into the SmaI and PstI sites of pGEM3 plasmid. An antisense or sense RNA probe was made by linearizing the pGEM3-Mizl plasmid with SmaI or PstI and transcribed with SP6 or T7 RNA polymerase (Ambion) in the presence of [35S]UTP (>1000 Ci/mmol; Amersham). The protocol used to fix and embed C3H and BALB/c mouse embryos is described in detail by Lyons et al. (1990) . Briefly, embryos were fixed in 4% paraformaldehyde in PBS, dehydrated and infiltrated with paraffin and sectioned. Sections (5 /~m) were mounted on the same polylysine-coated slide for hybridization. Sections were hybridized overnight at 52°C in 50% deionized formamide, 0.3 M NaC1, 20 mM Tris-HC1 (pH 7.4), 5 mM EDTA, 10 mM sodium phosphate, 10% dextran sulfate, lx Denhardt's, 50/zg/ml total yeast RNA and 50000-75000 cpm//~135S-labeled antisense or sense probe. The tissue was subjected to stringent washing at 65°C in 50% formamide, 2x SSC, 10 mM DTT and washed in PBS before being treated with 20 t~g/ml RNase A at 37°C for 30 min. Following a wash in 2x SSC and 0.1x SSC for 15 min at 37°C, the slides were dehydrated and dipped in Kodak NTB-2 nuclear track emulsion and exposed for 1 week in light tight boxes with desiccant at 4°C. Photographic development was carded out in Kodak D-19. Slides were analyzed using both light field and dark field optics of a Zeiss Axiophot microscope.
Note added in proof
The Mizl sequence has been submitted to Genbank. Recently, Busch and colleagues described (in Genbank) an apparent human homologue of Mizl, designated RGu binding ProteinS (accession number 1696007).
